MeiraGTx Holdings PLC

MGTX Healthcare Biotechnology

MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.

9.28 0.61 −6.17%
Market cap
$949.9M
P/E
12.2×
Fwd P/E
−5.6×
Dividend yield
—
F-score
5/9
Altman Z
−4.39
Beneish M
−3.01
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
17.78 0.00 0.00 0.00

+8 more quarters

P/S ratio
3.11 8.83 7.86 24.30
P/FCF ratio
122.01 164.35 0.00 0.00
P/Operating CF
(32.05) 39.53 13.71 (54.54)
P/B ratio
5.72 0.00 0.00 0.00
Price to Tangible BV
5.73 0.00 0.00 0.00
EV/Sales
3.00 8.55 7.66 24.18
EV/EBITDA
6.04 0.00 0.00 0.00
EV/Operating CF
87.08 82.42 (13.44) (5.70)
EV/FCF
117.75 159.27 (12.45) (5.50)
Quick Ratio
3.23 0.51 0.69 0.17
Current Ratio
3.76 0.55 0.75 0.22
Net Debt/EBITDA
(0.17) 0.58 (0.54) 0.08
Debt/Assets
25.25% 20.35% 20.37% 6.09%
Debt/Equity
0.46 (0.86) (8.60) (0.28)
Asset Turnover
1.34 0.34 0.32 0.11
Operating CF/Net income
(0.24) (0.38) 3.09 0.24
Capex/Depreciation
(0.10) (0.61) (0.20) (0.16)
Interest Coverage
69.66 (14.33) 8.67 (15.02)
Research and Development Expense of Revenue
17.99% 10,916.04% 40.88% 7,934.63%
Selling, General and Administrative Expense of Revenue
3.74% 3,047.10% 23.36% 3,320.98%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.18% 1,247.10% 7.43% 1,451.95%
Graham Net Nets
0.03 (0.29) (0.25) (0.29)
Graham Number
6.35 4.88 1.52 4.88
Earnings Yield
5.63% (17.09%) (17.86%) (25.64%)
Free Cash Flow Yield
0.82% 0.61% (7.83%) (18.09%)
Revenue per Share
3.52 0.00 0.94 0.01
Operating CF per Share
(0.42) 0.22 0.58 (0.15)
Capex per Share
0.00 (0.02) (0.01) (0.01)
Free Cash Flow per Share
(0.43) 0.19 0.57 (0.16)
Cash per Share
1.57 0.88 0.82 0.18
Shareholders Equity per Share
2.36 (0.71) (0.07) (0.50)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
2.36 (0.71) (0.07) (0.50)
Free Cash Flow
(38.87) 15.80 45.95 (12.76)
Working Capital
160.25 (79.93) (30.79) (118.75)
Capital Expenditures
(0.33) (2.01) (0.68) (0.55)
Net Current Asset Value
37.68 (206.58) (158.46) (195.85)
EV/EBIT
6.48 0.00 0.00 0.00
Capex to Sales
0.00 6.85 0.01 1.33
Price to Operating Income
6.71 0.00 0.00 0.00
Other line items
Average Receivables
25.53 11.46 13.98 10.12
Average Payables
18.63 18.47 16.83 25.52
Average Assets
297.58 234.33 257.09 244.48
Average Common Equity
109.37 (12.52) 31.02 27.59

Fold the line items

Columns are period end dates